The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-June 7, 2020
Open accessAbstract
As of June 16, 2020, the coronavirus disease 2019 (COVID-19) pandemic has resulted in 2,104,346 cases and 116,140 deaths in the United States.* During pregnancy, women experience immunologic and physiologic changes that could increase their risk for more severe illness from respiratory infections (1,2). To date, data to assess the prevalence and severity of COVID-19 among pregnant U.S. women and determine whether signs and symptoms differ among pregnant and nonpregnant women are limited. During January 22-June 7, as part of COVID-19 surveillance, CDC received reports of 326,335 women of reproductive age (15-44 years) who had positive test results for SARS-CoV-2, the virus that causes COVID-19. Data on pregnancy status were available for 91,412 (28.0%) women with laboratory-confirmed infections; among these, 8,207 (9.0%) were pregnant. Symptomatic pregnant and nonpregnant women with COVID-19 reported similar frequencies of cough (>50%) and shortness of breath (30%), but pregnant women less frequently reported headache, muscle aches, fever, chills, and diarrhea. Chronic lung disease, diabetes mellitus, and cardiovascular disease were more commonly reported among pregnant women than among nonpregnant women. Among women with COVID-19, approximately one third (31.5%) of pregnant women were reported to have been hospitalized compared with 5.8% of nonpregnant women. After adjusting for age, presence of underlying medical conditions, and race/ethnicity, pregnant women were significantly more likely to be admitted to the intensive care unit (ICU) (aRR = 1.5, 95% confidence interval [CI] = 1.2-1.8) and receive mechanical ventilation (aRR = 1.7, 95% CI = 1.2-2.4). Sixteen (0.2%) COVID-19-related deaths were reported among pregnant women aged 15-44 years, and 208 (0.2%) such deaths were reported among nonpregnant women (aRR = 0.9, 95% CI = 0.5-1.5). These findings suggest that among women of reproductive age with COVID-19, pregnant women are more likely to be hospitalized and at increased risk for ICU admission and receipt of mechanical ventilation compared with nonpregnant women, but their risk for death is similar. To reduce occurrence of severe illness from COVID-19, pregnant women should be counseled about the potential risk for severe illness from COVID-19, and measures to prevent infection with SARS-CoV-2 should be emphasized for pregnant women and their families.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SARS-CoV-2 infection is more severe in pregnant women compared to their non-pregnant counterparts, with an increased risk of hospital admission, ICU stay, and death 2 .”
From Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study (2021) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Garg, S., Kim, L., Whitaker, M., O’Halloran, A., Cummings, C., Holstein, R., Prill, M., Chai, S. J., Kirley, P. D., Alden, N. B., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6915e3 · Cited by 2,335
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
Sutton, D. M., Fuchs, K. M., D’Alton, M. E., & Goffman, D. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009316 · Cited by 1,028
Breslin, N., Baptiste, C. D., Gyamfi‐Bannerman, C., Miller, R., Martinez, R. H., Bernstein, K., Ring, L. E., Landau, R., Purisch, S. E., Friedman, A. M., et al. (2020) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2020.100118 · Cited by 792
Collin, J., Byström, E., Carnahan, A., & Ahrne, M. (2020) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13901 · Cited by 257
Severe Obstetric Morbidity in the United States: 1998–2005
Kuklina, E. V., Meikle, S., Jamieson, D. J., Whiteman, M. K., Barfield, W. D., Hillis, S. D., & Posner, S. F. (2009) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181954e5b · Cited by 211
Prevalence of SARS-CoV-2 Among Patients Admitted for Childbirth in Southern Connecticut
Campbell, K. H., Tornatore, J. M., Lawrence, K. E., Illuzzi, J. L., Sussman, L. S., Lipkind, H. S., & Pettker, C. M. (2020) · JAMA · doi:10.1001/jama.2020.8904 · Cited by 105
for the FLURISK-INVESTIGATORS, Mertz, D., Lo, C. K.-F., Lytvyn, L., Ortiz, J. R., & Loeb, M. B. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4318-3 · Cited by 99
Ramsey, P. S., & Ramin, K. D. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70217-5 · Cited by 93
Preparing for influenza after 2009 H1N1: special considerations for pregnant women and newborns
Rasmussen, S. A., Kissin, D. M., Yeung, L. F., MacFarlane, K. F., Chu, S. Y., Turcios-Ruiz, R. M., Mitchell, E. W., Williams, J. L., Fry, A. M., Hageman, J. C., et al. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.01.048 · Cited by 74
Creanga, A. A., Kamimoto, L., Newsome, K., D'Mello, T. A., Jamieson, D. J., Zotti, M. E., Arnold, K. E., Baumbach, J., Bennett, N. M., Farley, M. M., et al. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.02.037 · Cited by 58
Cited by
Sorted by citations
Allotey, J., Fernandez, S., Bonet, M., Stallings, E., Yap, M., Kew, T., Zhou, D., Coomar, D., Sheikh, J., Lawson, H., et al. (2020) · BMJ · doi:10.1136/bmj.m3320 · Cited by 2,304
Self-citationRisk factors for severe and critically ill COVID‐19 patients: A review
Gao, Y., Ding, M., Dong, X., Zhang, J., Azkur, A. K., Azkur, D., Gan, H. K., Sun, Y., Fu, W., Li, W., et al. (2020) · Allergy · doi:10.1111/all.14657 · Cited by 1,453
Zambrano, L. D., Ellington, S., Strid, P., Galang, R. R., Oduyebo, T., Tong, V. T., Woodworth, K. R., Nahabedian, J. F., Azziz-Baumgartner, E., Gilboa, S. M., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6944e3 · Cited by 1,207
Self-citationCoronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study
Gray, K. J., Bordt, E. A., Atyeo, C., Deriso, E., Akinwunmi, B., Young, N., Baez, A. M., Shook, L. L., Cvrk, D., James, K., et al. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.03.023 · Cited by 699
Wastnedge, E., Reynolds, R. M., van Boeckel, S. R., Stock, S. J., Denison, F. C., Maybin, J. A., & Critchley, H. (2020) · Physiological Reviews · doi:10.1152/physrev.00024.2020 · Cited by 698
Metadata
- Authors
- Ellington, S., Strid, P., Tong, V. T., Woodworth, K., Galang, R. R., Zambrano, L. D., Nahabedian, J., Anderson, K., & Gilboa, S. M.
- Affiliations
- CDC COVID-19 Emergency Response.
- Corresponding author
- Ellington, Sascha
- ORCID
- Venue
- MMWR. Morbidity and Mortality Weekly Report
- Published
- 2020-06-26
- Volume
- 69
- Issue
- 25
- Pages
- 769-775
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- PMC
- PMC7316319
- OpenAlex
- W3037168483
- Cited by
- 1,065
- References
- 10
- Citations by year
- 2026: 25 · 2025: 37 · 2024: 89 · 2023: 130 · 2022: 254 · 2021: 367 · 2020: 161
- FWCI
- 139.49
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- MMWR Morbidity and Mortality Weekly Report (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › COVID-19 Impact on Reproduction
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- COVID-19 pandemic, SARS-CoV-2, pregnancy, pregnant women, women of reproductive age, COVID-19 severity, hospitalization, intensive care unit admission, mechanical ventilation, COVID-19 mortality, symptom frequency, comorbidities, COVID-19 surveillance, United States, sex differences in disease outcomes, racial and ethnic disparities
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Adolescent, Adult, Female, Humans, Laboratories, Pneumonia, Viral, Pregnancy, Pregnancy Complications, Infectious, Severity of Illness Index, United States, Prevalence, Coronavirus Infections, Risk Assessment, Young Adult, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
